The construction of drug-resistant cancer cell lines by CRISPR/Cas9 system for drug screening
Author:
Funder
Minister of Science and Technology of China
National Natural Science Foundation of China
Publisher
Elsevier BV
Subject
Multidisciplinary
Reference29 articles.
1. MED12 controls the response to multiple cancer drugs through regulation of TGF-β receptor signaling;Huang;Cell,2012
2. Small molecule-capped gold nanoparticles as potent antibacterial agents that target gram-negative bacteria;Zhao;J Am Chem Soc,2010
3. Synergy of non-antibiotic drugs and pyrimidinethiol on gold nanoparticles against superbugs;Zhao;J Am Chem Soc,2013
4. Nanopreparations to overcome multidrug resistance in cancer;Patel;Adv Drug Deliv Rev,2013
5. Microfluidic synthesis of rigid nanovesicles for hydrophilic reagents delivery;Zhang;Angew Chem Int Ed,2015
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance;Nature Reviews Cancer;2024-07-24
2. Ultrasound triggered local sequential reactive oxygen species and nitric oxide release for enhanced cerasomal drug delivery;Chemical Engineering Journal;2024-04
3. Tumor-derived systems as novel biomedical tools—turning the enemy into an ally;Biomaterials Research;2023-11-09
4. CRISPR-Based Gene Editing: a Modern Approach for Study and Treatment of Cancer;Applied Biochemistry and Biotechnology;2023-09-22
5. Potential therapeutic targets of macrophages in inhibiting immune damage and fibrotic processes in musculoskeletal diseases;Frontiers in Immunology;2023-07-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3